Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBND
2726
DELISTED
Western Asset Total Return ETF
WBND
| $8.54M | ﹤0.01% |
+86,249
| New | +$8.64M |
|
2727
CALL
iShares TIPS Bond ETF
TIP
$14.7B
| $8.54M | ﹤0.01% |
66,900
-76,100
| -53% | -$9.6M |
|
2728
RingCentral
RNG
$5.39B
| $8.53M | ﹤0.01% |
22,501
-365,270
| -94% | -$114M |
|
2729
PUT
iRhythm Holdings
IRTC
$4.17B
| $8.52M | ﹤0.01% |
35,900
+15,700
| +78% | +$3.58M |
|
2730
CALL
Cardlytics
CDLX
$24.9M
| $8.51M | ﹤0.01% |
5,960
+900
| +18% | +$960K |
|
2731
Paylocity
PCTY
$7.87B
| $8.51M | ﹤0.01% |
41,328
+16,086
| +64% | +$3.09M |
|
2732
Ryanair
RYAAY
$30.5B
| $8.51M | ﹤0.01% |
+193,423
| New | +$7.59M |
|
|
NBIS
2733
PUT
Nebius Group N.V.
NBIS
$75.5B
| $8.5M | ﹤0.01% |
122,200
-24,100
| -16% | -$1.54M |
|
|
DGNS
2734
DELISTED
Dragoneer Growth Opportunities Corp. II Class A Ordinary Shares
DGNS
| $8.5M | ﹤0.01% |
+725,070
| New | +$8.19M |
|
2735
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $8.49M | ﹤0.01% |
98,294
+88,073
| +862% | +$7.61M |
|
2736
CALL
Cinemark Holdings
CNK
$4.33B
| $8.49M | ﹤0.01% |
487,600
+313,200
| +180% | +$3.94M |
|
2737
The RealReal
REAL
$1.39B
| $8.48M | ﹤0.01% |
433,967
-287,029
| -40% | -$4.43M |
|
2738
PUT
Bausch Health
BHC
$2.43B
| $8.47M | ﹤0.01% |
407,400
-89,400
| -18% | -$1.67M |
|
2739
CALL
iShares Russell 2000 Value ETF
IWN
$14.7B
| $8.47M | ﹤0.01% |
64,300
+10,700
| +20% | +$1.26M |
|
2740
CALL
LivePerson
LPSN
$35.2M
| $8.47M | ﹤0.01% |
9,073
+2,646
| +41% | +$2.28M |
|
2741
PUT
Bread Financial
BFH
$4.58B
| $8.46M | ﹤0.01% |
143,093
-12,906
| -8% | -$649K |
|
2742
CALL
iShares US Home Construction ETF
ITB
$2.36B
| $8.46M | ﹤0.01% |
151,600
-15,900
| -9% | -$896K |
|
|
FOLD
2743
DELISTED
Amicus Therapeutics
FOLD
| $8.46M | ﹤0.01% |
366,183
-536,548
| -59% | -$11M |
|
2744
PetMed Express
PETS
$39.5M
| $8.44M | ﹤0.01% |
263,216
+119,155
| +83% | +$3.67M |
|
2745
CALL
NRG Energy
NRG
$26.5B
| $8.43M | ﹤0.01% |
224,500
+95,700
| +74% | +$3.15M |
|
2746
PUT
Inovio Pharmaceuticals
INO
$113M
| $8.43M | ﹤0.01% |
79,342
-4,983
| -6% | -$663K |
|
2747
CALL
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $8.42M | ﹤0.01% |
72,530
+22,730
| +46% | +$2.03M |
|
|
SYSB
2748
iShares Systematic Bond ETF
SYSB
$1.17B
| $8.42M | ﹤0.01% |
82,056
-844
| -1% | -$85.9K |
|
|
CLDR
2749
PUT
DELISTED
Cloudera, Inc.
CLDR
| $8.41M | ﹤0.01% |
604,600
+1,400
| +0.2% | +$16K |
|
|
OACB
2750
DELISTED
Oaktree Acquisition Corp. II
OACB
| $8.41M | ﹤0.01% |
+801,469
| New | +$8.13M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.